IS3936A - Hliðstæð aðferð til framleiðslu á vatnsuppleysanlegum kamptóþesín afleiðum - Google Patents

Hliðstæð aðferð til framleiðslu á vatnsuppleysanlegum kamptóþesín afleiðum

Info

Publication number: IS3936A
Authority: IS; Iceland
Prior art keywords: production; water; analogous method; camptothecin derivatives; soluble camptothecin
Prior art date: 1991-10-29

Application number

IS3936A

Other languages

English (en)

Other versions

IS1708B (is

Inventor

Joseph Luzzio Michael

M. Besterman Jeffrey

G. Evans Michael

Leslie Myers Peter

Original Assignee

Osi Pharmaceuticals, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-10-29

Filing date

1992-10-28

Publication date

1993-04-30

1992-10-28 Application filed by Osi Pharmaceuticals, Inc. filed Critical Osi Pharmaceuticals, Inc.

1993-04-30 Publication of IS3936A publication Critical patent/IS3936A/is

1998-12-16 Publication of IS1708B publication Critical patent/IS1708B/is

Links

VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical class C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/66—Nitrogen atoms not forming part of a nitro radical

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

IS3936A 1991-10-29 1992-10-28 Hliðstæð aðferð til framleiðslu á vatnsuppleysanlegum kamptóþesín afleiðum IS1708B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US78427591A	1991-10-29	1991-10-29
US82672992A	1992-01-28	1992-01-28

Publications (2)

Publication Number	Publication Date
IS3936A true IS3936A (is)	1993-04-30
IS1708B IS1708B (is)	1998-12-16

Family

ID=27120258

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS3936A IS1708B (is)	1991-10-29	1992-10-28	Hliðstæð aðferð til framleiðslu á vatnsuppleysanlegum kamptóþesín afleiðum

Country Status (25)

Country	Link
EP (1)	EP0540099B1 (is)
JP (2)	JP3020760B2 (is)
KR (1)	KR100246154B1 (is)
CN (1)	CN1072683A (is)
AP (1)	AP306A (is)
AT (1)	ATE136898T1 (is)
AU (1)	AU657007B2 (is)
CA (1)	CA2081580A1 (is)
CZ (1)	CZ284023B6 (is)
DE (1)	DE69209969T2 (is)
DK (1)	DK0540099T3 (is)
ES (1)	ES2086643T3 (is)
FI (3)	FI104373B (is)
GR (1)	GR3020120T3 (is)
HU (2)	HU217970B (is)
IL (1)	IL103571A (is)
IS (1)	IS1708B (is)
MX (1)	MX9206211A (is)
MY (1)	MY108261A (is)
NO (1)	NO302073B1 (is)
NZ (1)	NZ244914A (is)
OA (1)	OA09767A (is)
RU (1)	RU2119921C1 (is)
SK (1)	SK279298B6 (is)
TW (1)	TW221994B (is)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5364858A (en) *	1987-03-31	1994-11-15	Research Triangle Institute	Camptothecin analogs as potent inhibitors of topoisomerase I
US5552154A (en) *	1989-11-06	1996-09-03	The Stehlin Foundation For Cancer Research	Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
US6080751A (en) *	1992-01-14	2000-06-27	The Stehlin Foundation For Cancer Research	Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof
US6005537A (en)	1992-08-21	1999-12-21	Hitachi, Ltd.	Liquid-crystal display control apparatus
AP9300587A0 (en) *	1992-11-12	1995-05-05	Glaxo Inc	Water soluble camptothecin derivatives.
ATE388706T1 (de) *	1993-01-15	2008-03-15	Stehlin Foundation For Cancer	Die verwendung von wasserunlöslichem s- camptothecin mit geschlossenem lactonring für die herstellung eines medikamentes zur behandlung von darmkrebs
US5369127A (en) *	1993-04-21	1994-11-29	Allergan, Inc.	1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents
IS4152A (is) *	1993-04-29	1994-10-30	Glaxo Inc.	Vatnsuppleysanlegar Camptothecin afleiður og aðferð til framleiðslu þeirra
NZ266094A (en) *	1993-05-03	1997-10-24	Smithkline Beecham Corp	Quinolinone derivatives; compounds, pharmaceutical formulations
US5447936A (en) *	1993-12-22	1995-09-05	Bionumerik Pharmaceuticals, Inc.	Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof
US5491237A (en) *	1994-05-03	1996-02-13	Glaxo Wellcome Inc.	Intermediates in pharmaceutical camptothecin preparation
IT1269862B (it) *	1994-05-30	1997-04-15	Indena Spa	Alcaloidi da mappia foetida, loro uso e formulazioni che li contengono
US5646159A (en) *	1994-07-20	1997-07-08	Research Triangle Institute	Water-soluble esters of camptothecin compounds
KR960029336A (ko)	1995-01-09	1996-08-17	김충환	캄토테신 유도체, 그의 제조 방법 및 이를 함유하는 항암제
US5496952A (en) *	1995-02-07	1996-03-05	North Carolina State University	Method of making asymmetric DE ring intermediates for the synthesis of camptothecin and camptothecin analogs
US5670500A (en) *	1995-05-31	1997-09-23	Smithkline Beecham Corporation	Water soluble camptothecin analogs
EP0837850B1 (en) *	1995-06-27	2004-09-01	Takeda Chemical Industries, Ltd.	4-acylamino(halogeno) alkyl-quinoline derivatives, their preparation and their use as melatonin agonists
SG50747A1 (en) *	1995-08-02	1998-07-20	Tanabe Seiyaku Co	Comptothecin derivatives
AU7732996A (en) *	1995-11-22	1997-06-11	Research Triangle Institute	Camptothecin compounds with combined topoisomerase i inhibition and dna alkylation properties
CA2192725C (en)	1995-12-28	2004-04-20	Kenji Tsujihara	Camptothecin derivatives
BR9710988A (pt) *	1996-06-27	2002-01-15	Ligand Pharm Inc	Método e compostos moduladores receptores de androgênio
SG104284A1 (en)	1996-10-30	2004-06-21	Tanabe Seiyaku Co	S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
US6559309B2 (en)	1996-11-01	2003-05-06	Osi Pharmaceuticals, Inc.	Preparation of a camptothecin derivative by intramolecular cyclisation
US6207673B1 (en)	1997-03-12	2001-03-27	The University Of North Carolina At Chapel Hill	Covalent conjugates of topoisomerase I and topoisomerase II inhibitors
US6046209A (en) *	1997-05-27	2000-04-04	Smithkline Beecham Corporation	Water soluble camptothecin analogs
EP1430934A1 (fr) *	1999-11-09	2004-06-23	Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.)	Produit comprenant un inhibiteur de la transduction des signaux des protéines G hétérotrimetriques en association avec un autre agent anti-cancéreux pour une utilisation thérapeutique dans le traitement du cancer
US6288072B1 (en) *	1999-12-29	2001-09-11	Monroe E. Wall	Camptothecin β-alanine esters with topoisomerase I inhibition
IL150953A0 (en)	2000-02-28	2003-02-12	Aventis Pharma Sa	A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer
US6545010B2 (en)	2000-03-17	2003-04-08	Aventis Pharma S.A.	Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer
US6548488B2 (en)	2000-03-17	2003-04-15	Aventis Pharma S.A.	Composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer
US6486320B2 (en)	2000-09-15	2002-11-26	Aventis Pharma S.A.	Preparation of camptothecin and of its derivatives
KR100742524B1 (ko)	2000-10-27	2007-08-02	아방티 파르마 소시에테 아노님	캄프토테신과 스틸벤 유도체를 포함하는 암 치료용 약제학적 병용제제
TW200306314A (en) *	2002-04-16	2003-11-16	Tanabe Seiyaku Co	Liquid preparation comprising camptothecin derivative and pharmaceutical composition producible by lyophilizing the preparation
ITRM20040240A1 (it) *	2004-05-13	2004-08-13	Ist Naz Stud Cura Dei Tumori	Camptotecine coniugate in posizione 7 con antagonisti delle integrine.
US20090104254A1 (en)	2004-12-22	2009-04-23	Rutgers, The State University Of New Jersey	Controlled Release Hydrogels
EP1998809B1 (en)	2006-03-30	2014-06-25	Drais Pharmaceuticals, Inc.	Camptothecin-cell penetrating peptide conjugates and pharmaceutical compositions containing the same
CN101407524B (zh) *	2007-10-09	2012-07-18	江苏先声药物研究有限公司	噁嗪骈喜树碱衍生物及其制备方法和用途
CN100592871C (zh) *	2008-03-14	2010-03-03	浙江林学院	一种杀虫剂组合物及其加工方法
ES2373172B1 (es) *	2010-07-16	2012-12-10	Consejo Superior De Investigaciones Científicas (Csic)	Proceso de obtención de derivados solubles en agua de 20 (s) camptotecina como agentes antitumorales.
US20140086975A1 (en)	2010-10-15	2014-03-27	Rutgers, The State University Of New Jersey	Hydrogel formulation for dermal and ocular delivery
US8980909B2 (en)	2011-01-12	2015-03-17	Crystal Biopharmaceutical Llc	HDAC inhibiting derivatives of camptothecin
IL277748B2 (en) *	2018-04-06	2024-07-01	Seagen Inc	Camptothecin peptide conjugates
TW202519270A (zh)	2018-06-07	2025-05-16	美商思進公司	喜樹鹼結合物
CN110590796B (zh) *	2018-06-12	2022-07-15	青岛海洋生物医药研究院股份有限公司	喜树碱衍生物及其制备方法和应用
EP3958977B1 (en) *	2019-04-26	2023-09-13	ImmunoGen, Inc.	Camptothecin derivatives
WO2023020605A1 (zh) *	2021-08-19	2023-02-23	江苏先声药业有限公司	喜树碱衍生物、其药物组合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5004758A (en) *	1987-12-01	1991-04-02	Smithkline Beecham Corporation	Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells

1992
- 1992-10-23 AT AT92203263T patent/ATE136898T1/de not_active IP Right Cessation
- 1992-10-23 EP EP92203263A patent/EP0540099B1/en not_active Expired - Lifetime
- 1992-10-23 DK DK92203263.6T patent/DK0540099T3/da active
- 1992-10-23 ES ES92203263T patent/ES2086643T3/es not_active Expired - Lifetime
- 1992-10-23 DE DE69209969T patent/DE69209969T2/de not_active Expired - Fee Related
- 1992-10-27 CZ CS923237A patent/CZ284023B6/cs not_active IP Right Cessation
- 1992-10-27 SK SK3237-92A patent/SK279298B6/sk unknown
- 1992-10-27 TW TW081108539A patent/TW221994B/zh active
- 1992-10-28 FI FI924878A patent/FI104373B/fi active
- 1992-10-28 NZ NZ244914A patent/NZ244914A/xx not_active IP Right Cessation
- 1992-10-28 FI FI982185A patent/FI982185A0/fi unknown
- 1992-10-28 MX MX9206211A patent/MX9206211A/es unknown
- 1992-10-28 HU HU9203384A patent/HU217970B/hu not_active IP Right Cessation
- 1992-10-28 NO NO924158A patent/NO302073B1/no unknown
- 1992-10-28 CN CN92113782A patent/CN1072683A/zh not_active Withdrawn
- 1992-10-28 CA CA002081580A patent/CA2081580A1/en not_active Abandoned
- 1992-10-28 AP APAP/P/1992/000439A patent/AP306A/en active
- 1992-10-28 IS IS3936A patent/IS1708B/is unknown
- 1992-10-28 AU AU27385/92A patent/AU657007B2/en not_active Ceased
- 1992-10-28 MY MYPI92001954A patent/MY108261A/en unknown
- 1992-10-28 JP JP4312862A patent/JP3020760B2/ja not_active Expired - Fee Related
- 1992-10-28 IL IL103571A patent/IL103571A/en not_active IP Right Cessation
- 1992-10-28 OA OA60295A patent/OA09767A/en unknown
- 1992-10-28 RU RU92004336A patent/RU2119921C1/ru not_active IP Right Cessation
- 1992-10-28 KR KR1019920019884A patent/KR100246154B1/ko not_active Expired - Fee Related
1995
- 1995-06-14 HU HU95P/P00203P patent/HU211349A9/hu unknown
1996
- 1996-05-31 GR GR960401497T patent/GR3020120T3/el unknown
1999
- 1999-11-02 JP JP31294099A patent/JP3229298B2/ja not_active Expired - Fee Related
2002
- 2002-06-07 FI FI20021090A patent/FI20021090L/fi not_active Application Discontinuation

Also Published As

Publication number	Publication date
HU211349A9 (en)	1995-11-28
DK0540099T3 (da)	1996-06-17
FI982185L (fi)	1998-10-08
SK323792A3 (en)	1998-09-09
AU2738592A (en)	1993-05-06
DE69209969T2 (de)	1996-09-12
CZ323792A3 (en)	1993-10-13
IL103571A (en)	1998-01-04
JPH05222048A (ja)	1993-08-31
OA09767A (en)	1993-11-30
FI104373B (fi)	2000-01-14
FI20021090A7 (fi)	2002-06-07
AP9200439A0 (en)	1992-10-31
CZ284023B6 (cs)	1998-07-15
TW221994B (is)	1994-04-01
NO924158D0 (no)	1992-10-28
JP2000109475A (ja)	2000-04-18
KR100246154B1 (ko)	2000-04-01
HU9203384D0 (en)	1993-01-28
HU217970B (hu)	2000-05-28
HUT65719A (en)	1994-07-28
AU657007B2 (en)	1995-02-23
FI924878A0 (fi)	1992-10-28
IS1708B (is)	1998-12-16
CA2081580A1 (en)	1993-04-30
FI924878A7 (fi)	1993-04-30
JP3229298B2 (ja)	2001-11-19
EP0540099B1 (en)	1996-04-17
DE69209969D1 (de)	1996-05-23
NZ244914A (en)	1995-01-27
GR3020120T3 (en)	1996-08-31
FI20021090L (fi)	2002-06-07
FI982185A7 (fi)	1998-10-08
IL103571A0 (en)	1993-03-15
NO924158L (no)	1993-04-30
MY108261A (en)	1996-09-30
JP3020760B2 (ja)	2000-03-15
NO302073B1 (no)	1998-01-19
MX9206211A (es)	1993-05-01
SK279298B6 (sk)	1998-09-09
RU2119921C1 (ru)	1998-10-10
ATE136898T1 (de)	1996-05-15
EP0540099A1 (en)	1993-05-05
AP306A (en)	1994-01-28
ES2086643T3 (es)	1996-07-01
CN1072683A (zh)	1993-06-02
FI982185A0 (fi)	1998-10-08

Publication	Publication Date	Title
IS3936A (is)	1993-04-30	Hliðstæð aðferð til framleiðslu á vatnsuppleysanlegum kamptóþesín afleiðum
IS3873A (is)	1992-12-04	Hliðstæð aðferð til framleiðslu á kristölluðum oxaþíólan afleiðum
IS3994A (is)	1993-10-17	Hliðstæð aðferð til framleiðslu á indole afleiðum
IS3915A (is)	1993-03-19	Aðferð til framleiðslu á benzanilíð afleiðum
IS3914A (is)	1993-03-19	Aðferð til framleiðslu á benzanilíð afleiðum
IS1611B (is)	1996-10-18	Hliðstæðar aðferðir til framleiðslu á Quinuclidine afleiðum
IS4148A (is)	1994-10-16	Hliðstæð aðferð til framleiðslu á 1,5 Benzodiazepine afleiðum
IS3954A (is)	1993-06-05	Hliðstæð aðferð við framleiðslu nýrra peptíðafleiða
IS4121A (is)	1994-07-21	Hliðstæð aðferð til framleiðslu á 2,6-Díamínópúrín afleiðum
IS3970A (is)	1993-07-22	Hliðstæð aðferð til framleiðslu á 1,5-benzódíazepín afleiðum
BG92674A (bg)	1993-12-24	Метод за получаване на производни на хинолина
FI893100L (fi)	1989-06-26	Analogiamenetelmä asyylideoksiribonukleosidijohdannaisten valmistamiseksi
FI893361L (fi)	1990-01-13	Menetelmä ACAT-inhiboivien kinoliinijohdannaisten valmistamiseksi
IS4219A (is)	1995-04-15	Aðferð til framleiðslu á Indole afleiðum
FI915741A7 (fi)	1991-12-05	Parannettu menetelmä substituoitujen isoflavonijohdannaisten valmistam iseksi
FI881904A7 (fi)	1989-10-23	Menetelmä 3-kefeemijohdannaisten valmistamiseksi
IS3827A (is)	1992-09-28	Hliðstæð aðferð við framleiðslu á pýrról[2,3 b]pýridínum
IS1795B (is)	2001-12-18	Hliðstæðar aðferðir til framleiðslu á bensópýran og skyldum LTB4 mótlyfjum
FI901605A0 (fi)	1990-03-30	Tieno-triatsolo-diatsepiinijohdosten valmistusmenetelmä
FI923498A7 (fi)	1993-02-07	Menetelmä 3-deoksimannosamiini-johdannaisten valmistamiseksi
NO903780D0 (no)	1990-08-29	Fremgangsmaate til fremstilling av epipodofyllotoksinaltrosid-derivater.
NO901071L (no)	1990-10-01	Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
NO904822D0 (no)	1990-11-06	Fremgangsmaate for fremstilling av pyridinderivater.
TR28699A (tr)	1997-01-28	Imidazopiridin türevlerinin hazirlanmasi icin yöntem.
FI921103A7 (fi)	1992-09-16	Menetelmä oksamidin valmistamiseksi